Cite
HARVARD Citation
Katz, M. et al. (2015). A randomized multicenter Phase Ib/II study to assess the immunological effect of chemoradiation therapy (CRT) in combination with pembrolizumab compared to CRT alone in resectable or borderline resectable pancreatic cancer. Journal for immunotherapy of cancer. 3 (2), pp. 1-3. [Online].